BMC Microbiology · 2012 · 24 citations · 31 references
Life SciencesImmunologyMicrobiologyHost-pathogen InteractionsImmunology Of Infectious DiseasesVaccinologyBacterial ImmunologyPathogen DetectionSerological DiagnosisAntigen Processing GenesCross-reactive AntigensO-antigen BiosynthesisPhenotypic Characterization Of IsolatesSerological IdentificationSerological Typing
BACKGROUND: Burkholderia pseudomallei is the etiological agent of melioidosis and a CDC category B select agent with no available effective vaccine. Previous immunizations in mice have utilized the lipopolysaccharide (LPS) as a potential vaccine target because it is known as one of the most important antigenic epitopes in B. pseudomallei. Complicating this strategy are the four different B. pseudomallei LPS O-antigen types: A, B, B2, and rough. Sero-crossreactivity is common among O-antigens of Burkholderia species. Here, we identified the presence of multiple B. pseudomallei O-antigen types and sero-crossreactivity in its near-neighbor species. RESULTS: PCR screening of O-antigen biosynthesis genes, phenotypic characterization using SDS-PAGE, and immunoblot analysis showed that majority of B. mallei and B. thailandensis strains contained the typical O-antigen type A. In contrast, most of B. ubonensis and B. thailandensis-like strains expressed the atypical O-antigen types B and B2, respectively. Most B. oklahomensis strains expressed a distinct and non-seroreactive O-antigen type, except strain E0147 which expressed O-antigen type A. O-antigen type B2 was also detected in B. thailandensis 82172, B. ubonensis MSMB108, and Burkholderia sp. MSMB175. Interestingly, B. thailandensis-like MSMB43 contained a novel serotype B positive O-antigen. CONCLUSIONS: This study expands the number of species which express B. pseudomallei O-antigen types. Further work is required to elucidate the full structures and how closely these are to the B. pseudomallei O-antigens, which will ultimately determine the efficacy of the near-neighbor B serotypes for vaccine development.
31
ACT: the Artemis comparison tool
Tim Carver, Kim Rutherford, Matthew Berriman et al. · Computer applications in the biosciences · 2005 · 1.7K citations · Full text
Bacterial lipopolysaccharides and innate immunity
C. Alexander, E.T. Rietschel · Journal of Endotoxin Research · 2001 · 987 citations
Public Health Assessment of Potential Biological Terrorism Agents
Lisa D. Rotz, Ali S. Khan, Scott R. Lillibridge et al. · Emerging infectious diseases · 2002 · 877 citations · Full text
Bacterial lipopolysaccharides and innate immunity.
Christian Alexander · PubMed · 2001 · 510 citations
Daniel Godoy, Gaynor Randle, Andrew Simpson et al. · Journal of Clinical Microbiology · 2003 · 499 citations · Full text